암환자의 임상연구에 대한 인식도 분석: 피험자 보호 관점에서

This study was designed to assess the degree of cancer patients’ awareness of the nature of clinical trials (CT) and to provide basic information for further research in developing systems of protection for vulnerable patients. Patients diagnosed with cancer and admitted for chemotherapy or receiving outpatient treatment were surveyed. The survey consisted of three parts to gather information on (1) patients’ awareness of the nature of CT in general, (2) patients’ awareness of CT from medical perspectives, and (3) the relationship between intent to participate in CT and financial compensation. Eighty-five patients participated in the survey. In the first part, many patients answered that they would participate in the study lest they be put at a disadvantage for not participating, while others said they would participate because they felt they would receive special treatment. In the second part, scores were lowest in men, the elderly, the unemployed, and those who participated as a result of decisions made by their spouses. In the third part, rewards influenced women more than men, and patients in their 60s expected a greater reward than those in other groups. Most cancer patients may not be sufficiently aware of the nature of CT and may be vulnerable when making decisions by themselves. Therefore, it is necessary for patients to receive more information on CT and for the information to be presented in terms that patients can easily understand. A system for the protection of vulnerable patients may also be needed.